Pharma Focus Asia Magazine

𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐬𝐞𝐝 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞: 𝐀 𝐍𝐞𝐰 𝐄𝐫𝐚 𝐟𝐨𝐫 𝐖𝐨𝐦𝐞𝐧'𝐬 𝐇𝐞𝐚𝐥𝐭𝐡 The future of healthcare for women is here, and it's personal! In a groundbreaking article by Mukhabbatkhon Mirzaolimova, Pharmaceutical Technical University, We delve into the transformative power of personalised medicine. This approach leverages the latest advancements in genomics, biomarkers, and targeted therapies to tailor treatments for complex women's health issues such as 𝐛𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫, 𝐞𝐧𝐝𝐨𝐦𝐞𝐭𝐫𝐢𝐨𝐬𝐢𝐬, 𝐚𝐧𝐝 𝐚𝐮𝐭𝐨𝐢𝐦𝐦𝐮𝐧𝐞 𝐝𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬. Join us as we explore the remarkable potential of #personalisedmedicine to improve treatment efficacy and patient outcomes. Discover the challenges we face and the promising solutions that lie ahead in this new frontier of healthcare. Read more about this exciting shift in women's health in 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚, 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞 𝟓𝟔. 👉 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐀𝐫𝐭𝐢𝐜𝐥𝐞: https://lnkd.in/gNTeEkQ7 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://lnkd.in/dxkGndFf 𝐒𝐭𝐚𝐲 𝐮𝐩𝐝𝐚𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐛𝐲 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐢𝐧𝐠 𝐡𝐞𝐫𝐞: https://lnkd.in/ghDSEXKj 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐨𝐮𝐫 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞𝐬: https://lnkd.in/eBQD_FfQ 𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐚𝐝𝐯𝐞𝐫𝐭𝐢𝐬𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚? 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐨𝐮𝐫 𝐦𝐞𝐝𝐢𝐚 𝐩𝐚𝐜𝐤 𝐡𝐞𝐫𝐞: https://lnkd.in/dbaBPC8E #personalisedmedicine #womenshealth #genomics #breastcancer #endometriosis #autoimmunedisorders #healthcareinnovation #pharmaceuticalscience #research #patientcare #healthcare #drugdevelopment #pharmafocus #womeninscience #pharmafocusasia #pharmamagazine #pharmaceuticals #biotechnology

𝐇𝐨𝐰 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝟒.𝟎 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 𝐈𝐦𝐩𝐫𝐨𝐯𝐞 𝐒𝐮𝐩𝐩𝐥𝐲 𝐂𝐡𝐚𝐢𝐧 𝐕𝐢𝐬𝐢𝐛𝐢𝐥𝐢𝐭𝐲 𝐚𝐧𝐝 𝐄𝐧𝐚𝐛𝐥𝐞 𝐀𝐜𝐜𝐮𝐫𝐚𝐭𝐞 𝐃𝐞𝐦𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐢𝐧𝐠 𝐢𝐧 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 In the dynamic world of 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠, 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝟒.𝟎 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 are redefining the game. By integrating advanced digital innovations, companies can significantly enhance supply chain visibility and enable accurate demand forecasting. This transformation not only streamlines operations but also ensures that the right products are available at the right time, ultimately leading to improved patient outcomes. In the latest article by Siddharth Singhal, co-founder & MD of Vibcare Pharma, discover how these technologies are optimizing processes and driving efficiency in the 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐬𝐞𝐜𝐭𝐨𝐫. 𝐃𝐨𝐧'𝐭 𝐦𝐢𝐬𝐬 𝐭𝐡𝐢𝐬 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐟𝐮𝐥 𝐫𝐞𝐚𝐝 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚, 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞 𝟓𝟔! 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐡𝐞𝐫𝐞: https://lnkd.in/gQNH5wMb 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://lnkd.in/dxkGndFf 𝐒𝐭𝐚𝐲 𝐮𝐩𝐝𝐚𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐛𝐲 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐢𝐧𝐠 𝐡𝐞𝐫𝐞: https://lnkd.in/ghDSEXKj 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐨𝐮𝐫 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞𝐬: https://lnkd.in/eBQD_FfQ 𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐚𝐝𝐯𝐞𝐫𝐭𝐢𝐬𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚? 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐨𝐮𝐫 𝐦𝐞𝐝𝐢𝐚 𝐩𝐚𝐜𝐤 𝐡𝐞𝐫𝐞: https://lnkd.in/dbaBPC8E #Pharmaceuticals #SupplyChain #DemandForecasting #DigitalTransformation #PharmaInnovation #VibcarePharma #Technology #Manufacturing #Healthcare #PharmaFocus #Efficiency #PatientCare #BusinessGrowth #FutureofPharma

𝐆𝐞𝐧𝐨𝐦𝐢𝐜𝐬 𝐢𝐧 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 In her groundbreaking article featured in "𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚, 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞 𝟓𝟔," Gulnaz Zaidi, Bioinformatics Scientist at miBiome Therapeutics LLP, explores how precision medicine is transforming patient care. By leveraging genetic and lifestyle information, precision medicine tailors treatment and prevention strategies to individual needs. Genomics research plays a pivotal role in this evolution, providing enhanced genetic testing and aiding in 𝐝𝐫𝐮𝐠 𝐭𝐚𝐫𝐠𝐞𝐭 𝐝𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲. Imagine a future where treatments are as unique as our DNA! 𝐉𝐨𝐢𝐧 𝐭𝐡𝐞 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐡𝐨𝐰 𝐠𝐞𝐧𝐨𝐦𝐢𝐜𝐬 𝐢𝐬 𝐬𝐡𝐚𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞. 🔗 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐡𝐞𝐫𝐞: https://lnkd.in/g-cGRqvw 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://lnkd.in/dxkGndFf 𝐒𝐭𝐚𝐲 𝐮𝐩𝐝𝐚𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐛𝐲 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐢𝐧𝐠 𝐡𝐞𝐫𝐞: https://lnkd.in/ghDSEXKj 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐨𝐮𝐫 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞𝐬: https://lnkd.in/eBQD_FfQ 𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐚𝐝𝐯𝐞𝐫𝐭𝐢𝐬𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚? 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐨𝐮𝐫 𝐦𝐞𝐝𝐢𝐚 𝐩𝐚𝐜𝐤 𝐡𝐞𝐫𝐞: https://lnkd.in/dbaBPC8E #genomics #precisionmedicine #bioinformatics #healthcareinnovation #mibiometherapeutics #genetictesting #drugdiscovery #pharmafocusasia #personalizedmedicine #futureofhealthcare #patientcare #medicalresearch #pharmafocus #healthtech #pharmaceuticals #magazine

The convergence of 𝐂𝐞𝐥𝐥 & 𝐆𝐞𝐧𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬 (𝐂𝐆𝐓) 𝐚𝐧𝐝 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐎𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧𝐬 (𝐂𝐃𝐌𝐎) is not just a trend—it's a necessity for the future of biotechnology! As CGT companies navigate the complexities of product lifecycles, making informed regulatory strategies and decisions about building or buying manufacturing capabilities is crucial. In her latest article, Christine Feaster, Quality Executive Partners, Inc. (QxP®), provides invaluable insights to help CGT companies thrive in this competitive landscape. Discover how to optimize your approach to meet both clinical and commercial needs effectively. 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 "𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚, 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞 𝟓𝟔" 𝐡𝐞𝐫𝐞:  https://lnkd.in/gUw-g4U8 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://lnkd.in/dxkGndFf 𝐒𝐭𝐚𝐲 𝐮𝐩𝐝𝐚𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐛𝐲 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐢𝐧𝐠 𝐡𝐞𝐫𝐞: https://lnkd.in/ghDSEXKj 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐨𝐮𝐫 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞𝐬: https://lnkd.in/gAdrmXdF 𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐚𝐝𝐯𝐞𝐫𝐭𝐢𝐬𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚? 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐨𝐮𝐫 𝐦𝐞𝐝𝐢𝐚 𝐩𝐚𝐜𝐤 𝐡𝐞𝐫𝐞: https://lnkd.in/dbaBPC8E #celltherapy #genetherapy #biotechnology #regulatorystrategy #manufacturing #pharmafocus #CGT #ATMP #CDMO #qualitymanagement #biotechinnovation #pharmaceuticals #clinicaltrials #healthcare #lifesciences #pharmafocusasia #magazine #pharmafocusmagazine #pharmaceuticals

Join the Pharma Focus Asia Magazine community by subscribing to our monthly newsletter! Get exclusive access to in-depth articles, industry reports, and interviews with leading experts in the 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐬𝐞𝐜𝐭𝐨𝐫. This is your chance to stay updated on the latest trends and innovations that shape our industry. Don’t forget to share this with your connections! 𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 𝐍𝐨𝐰: https://lnkd.in/gaF6fHbR #pharmafocusasia #pharmaceuticals #industryinsights #subscribenow #networking #pharmanews #innovation #healthcare #leadership #research #expertinterviews #pharmatrends #digitalhealth #careergrowth #knowledgesharing #pharmafocus #pharmafocusmagazine #newsletter #linkedinnewsletter #biotechnology

𝐁𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫𝐬 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐚𝐧𝐝 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬 Kirti Singh, 𝐏𝐨𝐬𝐭𝐝𝐨𝐜𝐭𝐨𝐫𝐚𝐥 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐬𝐭 𝐚𝐭 Eli Lilly and Company, explores the transformative role of novel biomarkers in clinical trials. With the ability to identify robust biomarkers, researchers are paving the way for innovative treatments for previously incurable diseases. This comprehensive overview discusses various biomarker categories and the challenges faced in biomarker research, shedding light on the evolving landscape of 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐝𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲. Dive into this insightful piece featured in "𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚, 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞 𝟓𝟔," and discover the future of medicine! https://lnkd.in/gzFANYym 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://lnkd.in/dxkGndFf 𝐒𝐭𝐚𝐲 𝐮𝐩𝐝𝐚𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐛𝐲 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐢𝐧𝐠 𝐡𝐞𝐫𝐞: https://lnkd.in/ghDSEXKj 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐨𝐮𝐫 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞𝐬: https://lnkd.in/gAdrmXdF 𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐚𝐝𝐯𝐞𝐫𝐭𝐢𝐬𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚? 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐨𝐮𝐫 𝐦𝐞𝐝𝐢𝐚 𝐩𝐚𝐜𝐤 𝐡𝐞𝐫𝐞: https://lnkd.in/dbaBPC8E #biomarkers #drugdiscovery #clinicaltrials #pharmaceuticals #innovation #research #healthcare #medicalresearch #pharmafocus #pharmafocusasia #medicalinnovation #science #futureofmedicine #biotech #pharmamagazine #articles

𝐍𝐚𝐧𝐨𝐜𝐚𝐫𝐫𝐢𝐞𝐫𝐬 𝐢𝐧 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐓𝐡𝐞𝐫𝐚𝐩𝐲: 𝐌𝐲𝐭𝐡 𝐨𝐫 𝐌𝐢𝐫𝐚𝐜𝐥𝐞? Breast cancer presents a diverse set of challenges due to its genetic and clinical heterogeneity. Enter nanocarriers—a promising technological advancement that has the potential to 𝐫𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐢𝐳𝐞 𝐛𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭. By harmonizing nanocarriers with existing therapies, we can potentially minimize adverse effects, reduce metastasis, and prevent relapse. However, the question remains: how effectively can these nanoinnovations address the complexities of 𝐛𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫? This ongoing research highlights the need for further exploration and clinical translation of nanocarriers in therapy. 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐜𝐮𝐫𝐫𝐞𝐧𝐭 𝐥𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 𝐚𝐧𝐝 𝐟𝐮𝐭𝐮𝐫𝐞 𝐝𝐢𝐫𝐞𝐜𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐧𝐚𝐧𝐨𝐜𝐚𝐫𝐫𝐢𝐞𝐫𝐬 𝐢𝐧 𝐛𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐢𝐧 𝐭𝐡𝐞 𝐜𝐨𝐦𝐩𝐞𝐥𝐥𝐢𝐧𝐠 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐛𝐲 Usha Nalla and Dr. Neelesh Mehra PhD, NIPER Hyderabad 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐢𝐧 "𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚, 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞 𝟓𝟔" 𝐚𝐧𝐝 𝐛𝐞 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧! https://lnkd.in/gvTcWhNi 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://lnkd.in/dxkGndFf 𝐒𝐭𝐚𝐲 𝐮𝐩𝐝𝐚𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐛𝐲 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐢𝐧𝐠 𝐡𝐞𝐫𝐞: https://lnkd.in/ghDSEXKj 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐨𝐮𝐫 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞𝐬: https://lnkd.in/gAdrmXdF 𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐚𝐝𝐯𝐞𝐫𝐭𝐢𝐬𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚? 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐨𝐮𝐫 𝐦𝐞𝐝𝐢𝐚 𝐩𝐚𝐜𝐤 𝐡𝐞𝐫𝐞: https://lnkd.in/dbaBPC8E #breastcancer #nanocarriers #cancertherapy #healthcareinnovation #pharmafocus #cancerresearch #medicaltechnology #oncology #patientcare #futureofmedicine #bioengineering #pharmaceuticals #nanotechnology #clinicalresearch #cancerawareness

𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐓𝐨𝐝𝐚𝐲: 𝐋𝐨𝐨𝐤𝐢𝐧𝐠 𝐛𝐚𝐜𝐤, 𝐥𝐨𝐨𝐤𝐢𝐧𝐠 𝐟𝐨𝐫𝐰𝐚𝐫𝐝 In the latest op-ed by Mahesh Narayan, FRSC, 𝐁𝐢𝐨𝐩𝐡𝐲𝐬𝐢𝐜𝐢𝐬𝐭 𝐚𝐭 𝐓𝐡𝐞 𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲 𝐨𝐟 𝐓𝐞𝐱𝐚𝐬, we explore the groundbreaking intersection of AI and ML in drug discovery. As we stand at the precipice of a new era, the ability to predict biological structures such as proteins, 𝐃𝐍𝐀, 𝐚𝐧𝐝 𝐑𝐍𝐀 is transforming the landscape. This innovation not only enhances our understanding but also accelerates the synthesis and development of small-molecule agonists and antagonists. Join us as we look back at the milestones of #drugdiscovery and peer into the future of biopharmaceuticals. Discover how these advancements can lead to more effective therapies for complex diseases. 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐢𝐧 "𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚, 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞 𝟓𝟔" 𝐚𝐧𝐝 𝐛𝐞 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧!  𝐑𝐞𝐚𝐝 𝐀𝐫𝐭𝐢𝐜𝐥𝐞: https://lnkd.in/gNvQEny3 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://lnkd.in/dxkGndFf 𝐒𝐭𝐚𝐲 𝐮𝐩𝐝𝐚𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐛𝐲 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐢𝐧𝐠 𝐡𝐞𝐫𝐞: https://lnkd.in/ghDSEXKj 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐨𝐮𝐫 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞𝐬: https://lnkd.in/gAdrmXdF 𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐚𝐝𝐯𝐞𝐫𝐭𝐢𝐬𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚? 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐨𝐮𝐫 𝐦𝐞𝐝𝐢𝐚 𝐩𝐚𝐜𝐤 𝐡𝐞𝐫𝐞: https://lnkd.in/dbaBPC8E #drugdiscovery #biophysics #ai #ml #pharmaceuticals #biotechnology #innovation #healthcare #research #pharmafocusasia #futureofmedicine #smallmolecules #medicalresearch #therapeutics #Utexas #pharmafocus #pharmaceuticals #pharmafocusmagazine #magazine

𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐟𝐨𝐫 𝐈𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐨𝐫𝐲 𝐁𝐨𝐰𝐞𝐥 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐈𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐨𝐫𝐲 𝐁𝐨𝐰𝐞𝐥 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 (𝐈𝐁𝐃) patients often face challenges with conventional treatments due to systemic side effects and low drug efficacy. But new hope is on the horizon! Julia Mantaj, Lecturer in Biomedical Science at Anglia Ruskin University, explores revolutionary drug delivery strategies in her latest article. Discover how advanced technologies like enteric-coated microneedle pills, nanoparticles, liposomes, and hybrid systems are transforming IBD treatment. These novel approaches aim to target affected areas more precisely, reduce side effects, and improve patient outcomes. 𝐑𝐞𝐚𝐝 𝐭𝐡𝐢𝐬 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐟𝐮𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 "𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚, 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞 𝟓𝟔" 𝐚𝐧𝐝 𝐥𝐞𝐚𝐫𝐧 𝐡𝐨𝐰 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐢𝐬 𝐬𝐡𝐚𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐈𝐁𝐃 𝐭𝐡𝐞𝐫𝐚𝐩𝐲! 👉 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞: https://lnkd.in/gmZXS4Fq 👉 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://lnkd.in/dxkGndFf 👉𝐒𝐭𝐚𝐲 𝐮𝐩𝐝𝐚𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐛𝐲 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐢𝐧𝐠 𝐡𝐞𝐫𝐞: https://lnkd.in/ghDSEXKj 🔗𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐨𝐮𝐫 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞𝐬: https://lnkd.in/gAdrmXdF 👉𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐚𝐝𝐯𝐞𝐫𝐭𝐢𝐬𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚? 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐨𝐮𝐫 𝐦𝐞𝐝𝐢𝐚 𝐩𝐚𝐜𝐤 𝐡𝐞𝐫𝐞: https://lnkd.in/dbaBPC8E #IBD #drugdelivery #biomedicine #healthcareinnovation #pharma #biotech #research #inflammation #therapeutics #nanotechnology #pharmacology #medicalscience #healthcare #patientcare #pharmafocusasia #pharmafocus #pharmamagazine #magazine #pharmafocusarticles #articles #pharmaceuticals

𝐓𝐡𝐞 𝐒𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐜𝐞 𝐨𝐟 𝐌𝐢𝐜𝐫𝐨𝐑𝐍𝐀𝐬 𝐢𝐧 𝐂𝐚𝐧𝐜𝐞𝐫: 𝐀 𝐛𝐫𝐢𝐞𝐟 𝐨𝐯𝐞𝐫𝐯𝐢𝐞𝐰 𝐌𝐢𝐜𝐫𝐨𝐑𝐍𝐀𝐬 (𝐦𝐢𝐑𝐍𝐀𝐬) are revolutionizing cancer research and treatment. As pivotal regulators of gene expression, these small non-coding RNAs can act as either oncogenes or tumor suppressors, making them essential in understanding 𝐜𝐚𝐧𝐜𝐞𝐫 𝐛𝐢𝐨𝐥𝐨𝐠𝐲. Recent advancements in miRNA-targeted therapeutics have shown promising results, with several candidates progressing to clinical development. This surge highlights the growing integration of 𝐦𝐢𝐑𝐍𝐀𝐬 𝐢𝐧 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐭𝐫𝐢𝐚𝐥𝐬, 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬, 𝐚𝐧𝐝 𝐝𝐫𝐮𝐠 𝐭𝐞𝐬𝐭𝐢𝐧𝐠. Our latest article, co-authored by Ancuta Jurj and George Calin, MD Anderson Cancer Center, delves into the significance of miRNAs in cancer therapeutic strategies. We explore their dual roles, the challenges in their application, and their potential as 𝐛𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫𝐬 𝐟𝐨𝐫 𝐩𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞. Join us in uncovering how miRNAs could transform cancer treatment and improve patient outcomes: https://lnkd.in/gZmv4mW5 👉 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://lnkd.in/dxkGndFf 👉𝐒𝐭𝐚𝐲 𝐮𝐩𝐝𝐚𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐛𝐲 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐢𝐧𝐠 𝐡𝐞𝐫𝐞: https://lnkd.in/ghDSEXKj 🔗𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐨𝐮𝐫 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞𝐬: https://lnkd.in/gAdrmXdF 👉𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐚𝐝𝐯𝐞𝐫𝐭𝐢𝐬𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚? 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐨𝐮𝐫 𝐦𝐞𝐝𝐢𝐚 𝐩𝐚𝐜𝐤 𝐡𝐞𝐫𝐞: https://lnkd.in/dbaBPC8E #MicroRNA #cancerresearch #biomarkers #oncology #pharmafocus #personalizedmedicine #clinicaltrials #cancertreatment #biotechnology #futureofmedicine #medicalresearch #pharmafocusasia #magazine #pharmafocusmagazine #pharmaarticles #pharmaceuticals